What is Alan Rolfe's NPI number?

Alan Rolfe's National Provider Identifier (NPI) is 1295899953, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Alan Rolfe's specialty?

Alan Rolfe is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Alan Rolfe located?

Alan Rolfe's practice location on file with NPPES is 8505 Arlington Blvd Ste 210, Fairfax, VA 22031-4630.

What is Alan Rolfe's phone number?

The practice phone number listed in the NPPES registry for Alan Rolfe is (703) 846-0076.

Does Alan Rolfe accept Medicare?

Alan Rolfe is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Alan Rolfe's NPI active?

Yes — Alan Rolfe's NPI (1295899953) is active in the NPPES registry as of the last update on 2024-06-13.

IndividualActiveAccepts Medicare

Alan Rolfe, M.D.

NPI 1295899953 · Dermatology Physician · Fairfax, VA

Alan Rolfe, M.D. is a Dermatology Physician provider in Fairfax, VA (NPI 1295899953).

Provider details

NPI number: 1295899953
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: Yes
License: 0101040397 (VA)

Practice location

8505 Arlington Blvd Ste 210

Fairfax, VA 22031-4630

Phone: (703) 846-0076

Fax: (703) 846-0025

Street-level locationGet directions

More VA providers

Mailing address

4646 Sunsail Cir

Destin, FL 32541-4756

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101040397 (VA)
Allopathic & Osteopathic Physicians
Dermatopathology Physician207ND0900XLicense 0101040397 (VA)
Allopathic & Osteopathic Physicians
Pediatric Dermatology Physician207NP0225XLicense 0101040397 (VA)
Allopathic & Osteopathic Physicians
Procedural Dermatology Physician207NS0135XLicense 0101040397 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(70/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
451 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	211	$8
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	75	$99
Destruction of Precancer Skin Growth, 1 Growth17000	58	$55
Destruction of Skin Growth, 1-14 Growths17110	31	$119
Biopsy of Related Skin Growth, First Growth11102	24	$94
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	40	22
Triamcinolone Acetonide	31	23
Clobetasol Propionate	14	11
Dupilumabbrand: Dupixent Pen	13	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$350 across 8 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-12-20
Last updated: 2024-06-13
Certified: 2024-06-13

Frequently asked questions

What is Alan Rolfe's NPI number?: Alan Rolfe's National Provider Identifier (NPI) is 1295899953, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Alan Rolfe's specialty?: Alan Rolfe is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Alan Rolfe located?: Alan Rolfe's practice location on file with NPPES is 8505 Arlington Blvd Ste 210, Fairfax, VA 22031-4630.
What is Alan Rolfe's phone number?: The practice phone number listed in the NPPES registry for Alan Rolfe is (703) 846-0076.
Does Alan Rolfe accept Medicare?: Alan Rolfe is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Alan Rolfe's NPI active?: Yes — Alan Rolfe's NPI (1295899953) is active in the NPPES registry as of the last update on 2024-06-13.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	211	$8
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	75	$99
Destruction of Precancer Skin Growth, 1 Growth17000	58	$55
Destruction of Skin Growth, 1-14 Growths17110	31	$119
Biopsy of Related Skin Growth, First Growth11102	24	$94
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	40	22
Triamcinolone Acetonide	31	23
Clobetasol Propionate	14	11
Dupilumabbrand: Dupixent Pen	13	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$350 across 8 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments